Breast Cancer Clinical Trial

Improving Evidence-Based Care for Cancer Patients

Summary

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
21 years of age or older at time of study registration
Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.

Exclusion Criteria:

Patients with primary central nervous system malignancies will be excluded.
Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
Patients who are unable to provide informed consent

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT03207594

Recruitment Status:

Active, not recruiting

Sponsor:

Medical University of South Carolina

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Medical University of South Carolina
Charleston South Carolina, 29425, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

128

Study ID:

NCT03207594

Recruitment Status:

Active, not recruiting

Sponsor:


Medical University of South Carolina

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.